[Abstract Only] Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
5 Aug, 2019 | 01:40h | UTCIbrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Survival increased in chronic lymphocytic leukemia patients treated with ibrutinib and rituximab – 2 Minute Medicine (free)